Log in
Enquire now
‌

US Patent 10407396 Crystalline form of selexipag

Patent 10407396 was granted and assigned to Apotex on September, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Apotex
Apotex
0
Current Assignee
Apotex
Apotex
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
104073960
Patent Inventor Names
Katherine A. Rantanen0
Bahareh Khalili0
Fabio E. S. Souza0
Jenny L. Gerster0
Allan W. Rey0
Annyt Bhattacharyya0
Date of Patent
September 10, 2019
0
Patent Application Number
161852230
Date Filed
November 9, 2018
0
Patent Citations
‌
US Patent 10040771 Method for preparing prostacyclin receptor agonist 4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]-1-butanol
‌
US Patent 10188648 Solid state forms of selexipag
Patent Primary Examiner
‌
Alexander R Pagano
0
Patent abstract

The present invention provides a novel crystalline form of Selexipag, Selexipag Form APO-I, which is a methanol solvate of Selexipag, compositions thereof, and the use of this crystalline form in the treatment of pulmonary arterial hypertension.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10407396 Crystalline form of selexipag

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.